Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.

Source:http://linkedlifedata.com/resource/pubmed/id/21296403

Lancet 2011 Feb 26 377 9767 721-31

Download in:

View as

General Info

PMID
21296403